{
    "nctId": "NCT06180460",
    "briefTitle": "CALM: Managing Distress in Malignant Brain Cancer",
    "officialTitle": "Managing Distress in Malignant Brain Cancer - Phase IIc RCT",
    "overallStatus": "RECRUITING",
    "conditions": "Brain Tumor, Brain Metastases, Brain Cancer, Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Melanoma, Metastatic Colon Cancer, Metastatic Kidney Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Assess the feasibility of the CALM intervention- Screening Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Self-reported diagnosis of brain metastasis (bMET) or a malignant primary brain tumor (PBT; specifically grade III or IV and CNS diffuse large B cell lymphomas)\\*\n* At least 2-weeks post-surgical resection or biopsy of the brain (if applicable)\n* Score \\> 20 on the TICS\n* Reported elevated depression (PHQ-9 score \u2265 10) OR death anxiety symptoms (DADDS score \u2265 15)\n* Ability to read, speak, and understand English\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Major communication difficulties which would prohibit the psychotherapeutic interaction\n* Inability to meet with the interventionist via an electronic device for telehealth intervention sessions\n* Inability to understand and provide informed consent\n* Prisoners\n* Medical, psychological, or social condition that, in the opinion of the principal investigator, may increase the participant's risk of adverse events and/or prohibit the individual's participation in the intervention.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}